Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Tejas Savant Reiterated (TXG) at Buy and Held Target at $65 on, Aug 7th, 2023


Published on 2024-10-28 05:35:48 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Reiterated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, Aug 7th, 2023.

Tejas has made no other calls on TXG in the last 4 months.



There are 7 other peers that have a rating on TXG. Out of the 7 peers that are also analyzing TXG, 0 agree with Tejas's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Tejas


  • Luke Sergott of "Barclays" Maintained at Buy with Increased Target to $66 on, Friday, August 4th, 2023
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $75 on, Friday, August 4th, 2023
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023
  • Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $65 on, Thursday, May 18th, 2023
  • Dan Brennan of "TD Cowen" Maintained at Buy with Increased Target to $66 on, Thursday, May 4th, 2023
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Increased Target to $68 on, Thursday, May 4th, 2023
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Thursday, May 4th, 2023
Contributing Sources